Evaluation of the relationship between C677T variants of methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in children receiving antiepileptic drug therapy

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 3, 2008, Pages 844-848

  Vurucu, Sebahattin ^a   Demirkaya, Erkan ^a   Kul, Mustafa ^a   Unay, Bulent ^a   Gul, Davut ^a   Akin, Ridvan ^a   Gokçay, Erdal ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Carbamazepin; Folate; Homocysteine; Methylenetetrahydrofolate reductase gene; Valproic acid

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTICONVULSIVE AGENT; CARBAMAZEPINE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; VALPROIC ACID;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; EPILEPSY; FEMALE; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; TREATMENT DURATION;

ADOLESCENT; ANALYSIS OF VARIANCE; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMISTRY; EPILEPSY; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; VALPROIC ACID; VITAMIN B 12;

EID: 39749105392     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.12.018     Document Type: Article

References (37)